Candida lusitaniae: An important emerging cause of candidemia

Infectious Diseases in Clinical Practice

Volumn 5, Issue 4, 1996, Pages 273-278

  Nguyen, M Hong ^a   Morris, Arthur J ^b   Dobson, Michael E ^a   Snydman, David R ^c   Peacock Jr , James E ^d   Rinaldi, Michael G ^e   Yu, Victor L ^a,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ADULT; AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA LUSITANIAE; CANDIDIASIS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; TREATMENT OUTCOME;

EID: 0030006783     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199605000-00010     Document Type: Article

References (28)

1. Young RC, Bennett JE, Geelhoed GW, et al. Fungemia with compromised host resistance. Ann Intern Med 1974; 80:605-12.
2. Klein JJ, Watanakunakorn C. Hospital-acquired fungemia. Its natural course and clinical significance. Am J Med 1979;67:51-8.
3. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-70.
4. Horn R, Hong B, Kiehn TE, et al. Fungemia in a cancer hospital. Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-55.
5. Dyess DL, Garrison N, Fry DE. Candida sepsis. Arch Surg 1985;120:345-48.
6. Nielsen H, Stenderup J, Bruun B. Fungemia in a university hospital 1984-1988. Scand J Infect Dis 1991;23:275-82.
7. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
8. Komshian SV, Uwaydah AK, Sobel JD, et al. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;3:379-90.
9. Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-C. albicans species and antifungal resistance. Am J Med. 1996:in press.
10. El-Zaatari M, Pasarell L, McGinnis MR, et al. Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol 1990;28:1938-41.
11. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. NCCLS 1992;12:1-21.
12. Pappagianis D, Collins MS, Hector R, et al. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 1979; 16:123-6.
13. Merz WG. Candida lusitaniae. frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984;20:1194-5.
14. Guinet R, Ghanas J, Goullier A, et al. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol 1983;18:443-4.
15. Terreni AA, Strohecker JS, Dowda H Jr. Candida lusitaniae septicemia in a patient on extended home intravenous hyperalimentation. J Med Vet Mycol 1986;25:63-5.
16. Sanchez PJ, Cooper BH. Candida lusitaniae: sepsis and meningitis in a neonate. Pediatr Infect Dis J 1987;8:758-9.
17. Merz WG, Sandford GR. Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol 1979;9:677-80.
18. Libertin CR, Wilson WR, Roberts GD. Candida lusitaniae - an opportunistic pathogen. Diagn Microbiol Infect Dis 1985;3:69-71.
19. Hadfield TL, Smith MB, Winn RE, et al. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987;9:1006-12.
20. Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 1989;27:236-40.
21. Yinnon AM, Woodin KA, Powell KR. Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis 1992;11:878-80.
22. Sanchez V, Vazquez JA, Barth-Jones D, et al. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 1992;30:3005-8.
23. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in C. krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-1315.
24. Persons DA, Laughlin M, Tanner D, et al. Fluconazole and Candida krusei fungemia [letter]. N Engl J Med 1991;325:1315.
25. Christenson JC, Guruswamy A, Mukwaya G, et al. Candida lusitaniae. an emerging human pathogen. Pediatr Infect Dis J 1987;6:755-7.
26. Bradsher RW, White FJ. Transient fungemia due to Candida lusitaniae [letter]. South Med J 1985;78:626-7.
27. Pensler MI, Krawczyk P, LeBar DW. Candida lusitaniae septicemia. Clin Microbiol Newsl 1985;7:86-7.
28. Thomas MG, Parr DH, di Menna M, et al. Candida lusitaniae septicemia: successful combination therapy. Clin Microbiol Newsl 1985;7:142-3.